Loading...
XWAR
KRK
Market cap9.50bUSD
Aug 28, Last price  
1,148.00PLN
Name

Krka dd Novo Mesto

Chart & performance

D1W1MN
XWAR:KRK chart
P/E
20.31
P/S
4.01
EPS
13.02
Div yield, %
3.05%
Shrs. gr., 5y
-0.17%
Rev. gr., 5y
5.88%
Revenues
Net income
CFO
Dividend
Jul 21, 202639.48399 PLN/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
IPO date
Feb 10, 1997
Employees
11,653
Domiciled in
SI
Incorporated in
SI

Valuation

No data to show